Login
Team of microbiology scientists discussing about virus development late at night. Modern equpped laboratory using pc and tablet taking notes to develop vaccine antibiotics against covid-19.
Scientist worried about virus evolution analysing DNA scan image standing in equipped laboratory typing at computer. Stuff examining vaccine development using high tech researching treatment
Viorolog researcher examining blood sample from test tube working in modern equipped laboratory. Scientist man analysing vaccine evolution using high tech researching diagnosis against covid19.
Scientist nurse typing medical reports on computer in scientific modern equipped laboratory. Examining vaccine evolution using high tech and technology researching treatment against covid19 virus
Team of medical researchers conducting vaccine development with help of high tech, test tubes, micropipette analysing results and planning next steps working at night in modern equipped laboratory
Group of researchers checking virus evolution conducting vaccine development with help of high tech, analysing results and planning next steps working late at night in modern equipped laboratory
Man biologist checking DNA informations typing on pc in modern equipped laboratory. Scientists examining vaccine evolution in medical lab using high tech, chemistry tools for scientific research.

1070388709

Se flere videoer

1064346499
Beskrivelse af Video

Stock-Video ID: 1064346499

Lab technicians making pharmaceutical research for antibiotics, curing disease with DNA enhancing drugs working at night. Team examining virus evolution using high tech for treatment against covid19

Vigtige oplysninger

Information om frigivelse: Underskrevet model- og ejendomsfrigivelse er arkiveret hos Shutterstock, Inc.

Video-formater

  • 4K • 3840 × 2160 pixels • MOV

  • HD • 1920 × 1080 pixels • MOV

  • SD • 852 × 480 pixels • MOV

  • Web • 426 × 240 pixels • MOV

Billedfrekvens

  • 23.98 FPS

Varighed

  • 0:11

Video-bidragsyder

DC StudioDC Studio

© 2003-2024 Shutterstock, Inc.